Skip to main content
OpenTrials

Clinical trial condition

Refractory Lymphoma

Explore clinical trials studying Refractory Lymphoma. Study availability and eligibility vary by location and protocol.

55 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Refractory Lymphoma trial results

Completed

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

NCT02323880

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT03323034

Conditions
Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 20 locations
View Trial Details
Completed

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02780804

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasm, +30 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details
Completed

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

NCT02343718

Conditions
Central Nervous System, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Children's and Women's Health Centre of BC Branch Vancouver, British Columbia, Canada
  • Izaak Walton Killam (IWK) Health Centre Halifax, Nova Scotia, Canada
  • McMaster Children's Hospital Hamilton, Ontario, Canada
  • Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada
View Trial Details
Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

NCT01742988

Conditions
Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine Chicago, Illinois, United States
View Trial Details
Completed

IACS-010759 in Advanced Cancers

NCT03291938

Conditions
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions